MATRIX RELOADED: Doctors Try New Techniques To Regrow Human Tissue
By Ron Winslow,
Wall Street Journal
| 02. 12. 2007
Five soldiers at a military base in Texas are about to participate in a remarkable test to see if they can regrow portions of fingers they lost in the war in Iraq.
Doctors plan to treat them with a fine powder called extracellular matrix, harvested from pig bladders. The material, found in all animals, is the scaffolding that cells latch onto as they divide and grow into tissue and body parts. In the human body, it was long thought to be inert. But scientists have discovered that it appears to activate latent biological processes that spur healing and regenerate tissue.
Medical researchers have been making intriguing progress in the field of regenerative medicine. The pilot test in Texas shows how doctors are trying to apply their recent discoveries to a pressing challenge: helping thousands of Americans returning from Iraq to recover from wounds that would have killed soldiers a generation ago.
Scientists have long been enthralled by the ability of animals such as salamanders, starfish and deer to regrow body parts lost due to injury or other causes. Cut off...
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Tina Stevens, CounterPunch | 12.11.2025
Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI mogul Sam Altman, cryptocurrency entrepreneur Brian Armstrong, venture capitalist Peter...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...